Skip to main content
. 2024 Mar 4;26:e53001. doi: 10.2196/53001

Table 1.

Baseline characteristics of the study sample (N=70).


Control group Treatment group Control vs treatment



t test (df) Chi-square (df) P value
Age (years), mean (SD; range) 67.91 (5.83; 60-85) 69.80 (5.36; 61-86) –1.41 (68) N/Aa .16
Gender, n (%) N/A 0.9 (1) .36

Female 30 (85) 27 (77)



Male 5 (14) 8 (22)


Race or ethnicity, n (%) N/A 5.4 (4) .25

African American or Black 4 (11) 5 (14)



American Indian 1 (3) 0 (0)



Asian or Pacific Islander 0 (0) 2 (6)



White, non-Hispanic 30 (86) 26 (74)



Mixed race or other 0 (0) 2 (5)


Education, n (%) N/A 2.9 (3) .41

High school or GEDb 4 (11) 6 (17)



Associate’s or some college 8 (23) 12 (34)



4-year college degree 13 (37) 12 (34)



Master’s degree or above 10 (29) 5 (14)


Household income (US $), n (%) N/A 2.5 (3) .47

<20,000 2 (6) 5 (15)



20,000-49,999 17 (49) 16 (47)



50,000-74,999 9 (26) 5 (15)



≥75,000 7 (20) 8 (23)


Living status, n (%) N/A 0.1 (1) .81

Lives with others 21 (60) 20 (57)



Lives alone 14 (40) 15 (43)


Marital status, n (%) N/A 4.7 (4) .30

Married 18 (51) 13 (37)



Living with a partner 1 (3) 1 (3)



Divorced or separated 6 (17) 14 (40)



Widowed 8 (23) 5 (14)



Never married 2 (6) 2 (6)


Count of chronic conditionsc, mean (SD; range) 2.31 (0.99; 0-5) 2.25 (1.27; 0-5) 0.2 (68) N/A .83
Mobility limitation indexd, mean (SD; range) 4.20 (2.29; 1-9) 4.71 (2.76; 0-10) –0.9 (68) N/A .40
Device ownership, n (%) N/A 0.7 (2) .69

No device ownership 2 (6) 2 (6)



Has tablet or iPad 4 (11) 2 (6)



Has laptop or PC 29 (83) 31 (89)


Ever received a depression diagnosise, n (%) N/A 0 (1) .99

No 13 (37) 13 (37)



Yes 22 (63) 22 (63)


Taking an antidepressant, n (%) N/A 0.6 (1) .45

No 21 (60) 24 (69)



Yes 14 (40) 11 (31)


PHQ-9f score, mean (SD; range) 11.29 (2.65; 8-18) 11.49 (2.63; 8-19) –0.3 (68) N/A .75

aN/A: not applicable.

bGED: General Educational Development Test.

cThe chronic disease count was the sum of self-reported conditions including hypertension, diabetes, chronic lung disease, chronic kidney disease, heart disease, stroke, arthritis, and cancer.

dThe mobility limitation index asks if a participant has difficulty with 11 tasks: running or jogging for a mile, walking several blocks, walking one block, sitting for 2 hours, standing for 30 minutes, getting up from a chair after sitting for a long period, climbing several flights of stairs, climbing 1 flight of stairs, walking across a room, using equipment or devices when crossing a room, and getting in or out of bed. “Yeses” were summed to create a total score, ranging from 0 to 11.

eParticipants were asked, “has a doctor, therapist, psychologist, or other health care provider ever told you that you have depression?”

fPHQ-9: Patient Health Questionnaire-9.